Good laboratory practice (GLP) as a quality assurance system Dusseldorf/Rostock – Rostock biotech company Cytocentrics AG, a subsidiary of Dusseldorf stars innovation AG, has today successfully completed the procedure for obtaining the GLP standards. “Good laboratory practice (GLP) is a quality assurance system that are concerned with the organisational process and the conditions, under which non-clinical health and environmental safety tests planned, carried out and monitored as well as the recording, archiving and reporting of tests.” This is the definition of good laboratory practice GLP principles of the Organization for economic cooperation and development (OECD), then in the EC directives and then into German law were adopted and enshrined in the legislation. Through the worldwide implementation and mutual acceptance of test data, GLP has like hardly another quality backup system to health and environmental protection as well as to the Contributed to animal welfare. Multinational companies can save around 70% of animal experiments on the basis of mutual recognition of GLP implementation E.g.. The Cytocentrics AG carries out by means of ion channel analysis of security checks for new drugs.
Thanks to GLP-standard, these tests international are recognised by all health authorities. This applies in particular to the American FDA. The Cytocentrics AG positions itself as a full service provider for the pharmaceutical industry. In addition to the Auftragsscreening, the Cytocentrics offers fully automated analyzers and standardized, ready to use cell cultures. The Cytopatch machine is an in-house development of the company. The device delivers best results at high throughput. The Cytocentrics AG is a company of stars innovation AG in Dusseldorf, Germany. The stars innovation AG is a pioneer in the field of growth financing for young high-tech companies. Stars innovation relies on new product developments, which are made possible by the use of nanotechnological methods.